10-K: Finnovate Acquisition Corp. Faces Delisting and Liquidity Concerns Amidst Repeated Business Combination Delays and Shareholder Redemptions

Sentiment:

Annual Report


Finnovate Acquisition Corp., a SPAC, reported a net loss for 2024 and continues to face significant challenges, including delisting from Nasdaq and substantial shareholder redemptions, as it repeatedly extends its deadline to complete a business combination with Scage International Limited.

Delay expectedThe company has repeatedly extended its business combination deadline: from May 8, 2023, to May 8, 2024, then to November 8, 2024, then to May 8, 2025, and most recently to November 8, 2025.The 'Outside Date' for the Scage Business Combination Agreement has been extended multiple times: from February 29, 2024, to October 31, 2024, then to March 31, 2025, and finally to July 31, 2025.The Reorganization deadline for Scage was extended from September 30, 2023, to July 20, 2024.
Capital raiseThe company has issued multiple unsecured promissory notes from its Sponsor and Sunorange to fund working capital deficiencies and extension payments, including a June 2023 Promissory Note (up to $1,200,000), a November 2023 Promissory Note (up to $1,500,000), a May 2024 Promissory Note (up to $225,000), and a November 2024 Promissory Note (up to $259,588).Scage also issued a January 2024 Promissory Note of up to $1,500,000 to Finnovate for working capital needs.The company's ability to obtain additional financing to complete its initial Business Combination is listed as a risk factor, indicating potential future capital needs.
Worse than expectedThe company reported a net loss of $215,486 for 2024, a significant deterioration from a net income of $2,494,909 in 2023.The Trust Account balance has been severely depleted due to continuous high shareholder redemptions across multiple extension votes, indicating a substantial loss of capital available for the business combination.The delisting from Nasdaq and subsequent trading on the OTC Markets represents a significant negative operational and financial outcome, impacting liquidity and investor perception.The identified material weakness in internal control over financial reporting indicates a fundamental deficiency in financial oversight and reporting processes.

Summary

  • Finnovate Acquisition Corp. (FNVT) is a blank check company formed to effect a business combination, with no operating revenues to date.
  • The company reported a net loss of $215,486 for the year ended December 31, 2024, compared to a net income of $2,494,909 in 2023.
  • As of December 31, 2024, the company had only $769 in cash outside its Trust Account and a working capital deficit of $5,086,771.
  • The Trust Account balance significantly decreased to $10,208,877 as of December 31, 2024, from $51,200,344 as of December 31, 2023, primarily due to multiple shareholder redemptions.
  • The company has repeatedly extended its deadline to complete a business combination, with the current deadline set for November 8, 2025.
  • Shareholder redemptions in connection with extension votes were substantial: 12,626,668 shares ($132.6 million) in May 2023, 2,374,826 shares ($26.9 million) in May 2024, 1,383,214 shares ($16.16 million) in November 2024, and 742,834 shares ($9.0 million) in May 2025.
  • The proposed business combination with Scage International Limited, a zero-emission solution provider, has seen its aggregate merger consideration reduced from $1.0 billion to $800 million.
  • Finnovate's securities were delisted from Nasdaq on November 12, 2024, and now trade on the OTC Markets under FNVUF, FNVTF, and FNVWF.
  • The company identified a material weakness in its internal control over financial reporting as of December 31, 2024, related to accounting for complex financial instruments, professional fees, prepaid expenses, and related party transactions.
  • The independent auditor, HTL International, LLC, expressed substantial doubt about the company's ability to continue as a going concern due to liquidity concerns and mandatory liquidation if the business combination is not completed by November 8, 2025.

Sentiment

Score: 2

Explanation: The sentiment is overwhelmingly negative due to significant financial losses, severe depletion of the Trust Account, repeated delays in the business combination, delisting from Nasdaq, and identified material weaknesses in internal controls. While the business combination proposal was approved by shareholders, the ongoing challenges and 'going concern' doubt overshadow this positive.

Positives

  • Shareholders approved the Scage Business Combination proposal on March 28, 2025, indicating a path forward for the SPAC.
  • The Sponsor and Sunorange have provided significant financial support through promissory notes and deposits into the Trust Account to facilitate extensions and cover working capital needs, totaling $1,468,264 deposited into the Trust Account for extensions as of December 31, 2024.
  • The company has established robust corporate governance policies, including an Insider Trading Policy and an Executive Compensation Clawback Policy, aligning with regulatory best practices.

Negatives

  • The company reported a net loss of $215,486 for the year ended December 31, 2024, a significant decline from a net income of $2,494,909 in 2023.
  • The Trust Account balance has severely depleted from $175,950,000 initially to $10,208,877 as of December 31, 2024, due to high redemption rates.
  • The company's securities were delisted from Nasdaq on November 12, 2024, and now trade on the less liquid OTC Markets, potentially impacting investor confidence and future capital raising efforts.
  • A material weakness in internal control over financial reporting was identified, indicating deficiencies in accounting for complex financial instruments and related party transactions.
  • The company has a working capital deficit of $5,086,771 as of December 31, 2024, highlighting severe liquidity issues outside the Trust Account.
  • The aggregate merger consideration for Scage was reduced from $1.0 billion to $800 million, suggesting a potential re-evaluation of the target's value or negotiation challenges.

Risks

  • The company may not be able to complete its initial Business Combination, including the Scage Business Combination, within the extended Combination Period ending November 8, 2025, leading to mandatory liquidation.
  • There is substantial doubt about the company's ability to continue as a going concern due to its limited cash outside the Trust Account and the mandatory liquidation if a business combination is not completed.
  • The company's delisting from Nasdaq could adversely affect the liquidity and trading of its securities and may hinder its ability to consummate an initial Business Combination or list Pubco's securities on Nasdaq.
  • High shareholder redemption rates significantly reduce the funds available in the Trust Account, potentially affecting the company's ability to complete a desirable business combination or optimize the combined company's capital structure.
  • The identified material weakness in internal control over financial reporting could lead to inaccurate financial reporting and adversely affect investor confidence.
  • The company's officers and directors may have conflicts of interest due to their involvement in other businesses and the potential for substantial personal profit from Founder Shares even if public investors experience losses.
  • Changes in international trade policies, tariffs, and treaties could negatively impact the target business (Scage) and the post-Business Combination company's operations and financial results.
  • The company is subject to the new 2024 SEC SPAC Rules, which may increase costs and time related to completing the business combination and could potentially subject the company to regulation under the Investment Company Act.

Future Outlook

The company's future outlook is highly dependent on the successful completion of the Scage Business Combination by November 8, 2025. Management intends to complete the business combination, but there is no assurance of success. The company may seek further extensions of the Combination Period, which would require shareholder approval and could lead to further redemptions. The post-Business Combination company (Pubco) will seek to be listed on Nasdaq, but there is no assurance of this listing, which could impact its ability to meet anticipated financing needs. The company is also evaluating the impact of new accounting standards (ASU 2023-09, ASU 2024-02, ASU 2024-03) on its future financial statements.

Management Comments

  • "Our Management Team is led by Calvin Kung, our Chief Executive Officer, and Wang Chiu (Tommy) Wong, our Chief Financial Officer."
  • "We must complete our initial Business Combination by November 8, 2025 (unless being extended by shareholders approval)."
  • "Our management has determined that the automatic liquidation, should a Business Combination not occur, and potential subsequent dissolution also raise substantial doubt about our ability to continue as a going concern for a period of time within one year after the date that the unaudited condensed financial statements are issued."
  • "While management intends to complete a Business Combination on or before November 8, 2025, it is uncertain whether we will be able to do so."
  • "Management believes that the audited financial statements included in this Report present fairly, in all material respects, our financial position, results of operations and cash flows of the periods presented."
  • "We have enhanced, and will continue to enhance, internal controls and procedures, including access to accounting literature, identification and consideration of third-party professionals with whom to consult regarding complex accounting applications and implementing additional layers of reviews in the financial close process."

Industry Context

Finnovate Acquisition Corp. operates as a Special Purpose Acquisition Company (SPAC), a segment of the financial industry that has faced increased regulatory scrutiny and market challenges, including higher redemption rates and delistings. The 2024 SEC SPAC Rules impose additional disclosure requirements and co-registrant obligations, increasing the complexity and cost of business combinations. The target, Scage International Limited, is in the zero-emission vehicle and e-fuel solutions sector in China, an industry experiencing rapid growth and significant investment, but also subject to evolving regulatory landscapes and intense competition.

Comparison to Industry Standards

  • Finnovate's high redemption rates across multiple extension votes (e.g., 742,834 shares in May 2025, 1,383,214 in Nov 2024) are indicative of a broader trend in the SPAC market where public shareholders increasingly redeem their shares, reducing the cash available for the business combination. This contrasts with earlier SPAC cycles that saw lower redemption rates.
  • The reduction of the merger consideration for Scage from $1.0 billion to $800 million suggests a re-evaluation of the target's valuation, which is not uncommon in a volatile market for SPAC targets, especially those in emerging or high-growth sectors like NEVs.
  • The delisting from Nasdaq and subsequent trading on OTC Markets is a significant negative deviation from industry standards for publicly traded companies, often signaling reduced investor confidence and liquidity compared to peers maintaining major exchange listings.
  • The repeated extensions of the business combination deadline (from May 2023 to November 2025) are a common characteristic of SPACs struggling to close deals, but Finnovate's frequency and the associated redemptions highlight a more pronounced challenge compared to successful SPACs that complete combinations within initial timelines.
  • The identified material weakness in internal control over financial reporting is a governance concern that places Finnovate below the expected standards for public companies, which are required to maintain effective internal controls under Sarbanes-Oxley.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chairman of the Board and Chief Executive OfficerDavid GershonCalvin KungMay 8, 2023Part of the Sunorange Investment and change in management.
Chief Financial Officer and DirectorRon GolanWang Chiu (Tommy) WongMay 8, 2023Part of the Sunorange Investment and change in management.
Chief Investment OfficerJonathan OphirMay 8, 2023Resignation as part of the Sunorange Investment.
Senior ConsultantUri ChaitchikMay 8, 2023Resignation as part of the Sunorange Investment.
DirectorMitch GarberUpon expiration of Waiting Period (post-May 8, 2023)Resignation as part of the Sunorange Investment.
DirectorGustavo SchwedUpon expiration of Waiting Period (post-May 8, 2023)Resignation as part of the Sunorange Investment.
DirectorNadav ZoharUpon expiration of Waiting Period (post-May 8, 2023)Resignation as part of the Sunorange Investment.
Independent Registered Public Accounting FirmMarcum LLPHTL International, LLCMarch 24, 2025Dismissal by Audit Committee and engagement of new firm.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Policy AdoptionAdopted an Executive Compensation Clawback Policy, effective October 2, 2023, to comply with SEC and Nasdaq rules, allowing for mandatory recovery of erroneously awarded incentive-based compensation from executive officers.2023-10-02Enhances accountability and aligns executive compensation with financial performance, reducing risk of misconduct-related financial misstatements.
Policy AdoptionAdopted Insider Trading Policies and Procedures, effective April 21, 2025, governing the purchase, sale, and other dispositions of company securities by directors, officers, and employees.2025-04-21Aims to prevent insider trading violations and promote compliance with securities laws, enhancing market integrity and investor trust.
Committee CompositionAudit Committee and Compensation Committee are each entirely composed of independent directors, meeting Nasdaq and SEC requirements.May 2023 (post-management change)Strengthens oversight and independence of financial reporting and executive compensation decisions.
Internal Control WeaknessIdentified a material weakness in internal control over financial reporting as of December 31, 2024, due to lack of accounting staff and resources with appropriate knowledge of U.S. GAAP, SEC reporting, and compliance.2024-12-31Indicates a significant deficiency that could lead to material misstatements in financial statements, requiring immediate remediation efforts to restore reliability and investor confidence.

Legal Proceedings

  • To the knowledge of management, there is no material litigation currently pending or contemplated against the company, its officers, or directors in their capacity as such, or against any of its property.

Related Party Transactions

  • The Sponsor purchased 4,312,500 Founder Shares for $25,000 in March 2021, representing approximately 20% of outstanding shares after IPO.
  • The Sponsor and EarlyBirdCapital purchased 8,800,000 Private Placement Warrants for $1.00 per warrant, generating $8,800,000 in gross proceeds.
  • The company paid the Sponsor $3,000 per month for office space, utilities, and administrative support services under an Administrative Services Agreement, which was terminated as of October 1, 2024.
  • The Sponsor and Sunorange have provided multiple interest-free promissory notes to the company for working capital and extension payments, including a June 2023 Promissory Note (up to $1,200,000), a November 2023 Promissory Note (up to $1,500,000), a May 2024 Promissory Note (up to $225,000), and a November 2024 Promissory Note (up to $259,588).
  • The outstanding balance of the Working Capital Loan from the Sponsor was canceled in full on May 8, 2023, as part of the Sunorange Investment, treated as an in-substance capital contribution.
  • On January 3, 2025, the Sponsor distributed all its Class A and Class B ordinary shares and private placement warrants to its constituent members, including CEO Calvin Kung and CFO Wang Chiu (Tommy) Wong.

Stakeholder Impact

  • **Shareholders**: Public shareholders have experienced significant dilution and value erosion due to repeated redemptions and the company's delisting from Nasdaq, limiting liquidity and trading options. The ongoing uncertainty about the business combination and the 'going concern' doubt pose further risks to their investment.
  • **Employees/Management**: The management team, particularly Calvin Kung and Wang Chiu (Tommy) Wong, have taken on significant responsibility in navigating the company through its challenges and securing extensions. Their compensation and future roles are tied to the successful completion of the business combination.
  • **Creditors**: The company's limited cash outside the Trust Account and the 'going concern' doubt raise concerns for creditors, although the Sponsor has agreed to indemnify the Trust Account against certain third-party claims to protect public shareholders' funds.
  • **Scage International Limited**: As the target company, Scage's valuation has been adjusted downwards, and the completion of the business combination is critical for its public listing and potential capital infusion. Delays and uncertainties from Finnovate could impact Scage's strategic plans.
  • **Sponsor/Related Parties**: The Sponsor and Sunorange have provided substantial financial support through loans and deposits, indicating their continued commitment, but also exposing them to financial risk if the business combination fails.

Next Steps

  • Complete the Scage Business Combination by the extended deadline of November 8, 2025.
  • Address the identified material weakness in internal control over financial reporting to ensure accurate and timely financial reporting.
  • Work towards fulfilling applicable exchange listing approvals for Pubco's securities post-business combination.
  • Continue to manage liquidity and working capital needs, potentially through further promissory notes or other financing arrangements.
  • Monitor and comply with the evolving 2024 SEC SPAC Rules and other regulatory requirements.

Key Dates

DateDescription
2021-03-15Finnovate Acquisition Corp. incorporated as a Cayman Islands exempted company.
2021-11-08Initial Public Offering (IPO) consummated, selling 15,000,000 Units at $10.00 per Unit.
2021-11-12Underwriters exercised full over-allotment option, selling an additional 2,250,000 Units.
2023-04-27Investment Agreement entered into with Sponsor and Sunorange, leading to management changes and Sunorange's acquisition of Insider Securities.
2023-05-08Extraordinary General Meeting (2023 EGM) held, approving extension of business combination deadline to May 8, 2024, and completing Sunorange Investment and Founder Share Conversion.
2023-05-18Redemptions from the 2023 EGM were effected, totaling approximately $132.6 million.
2023-06-02Issued a promissory note of up to $1,200,000 to the Sponsor to support the 2023 Extension.
2023-08-21Entered into the Business Combination Agreement with Scage Future, Hero 1, Hero 2, and Scage International Limited.
2023-08-29Engaged a third-party consultant for business combination target introductions.
2023-11-01Instructed trustee to liquidate Trust Account investments and hold funds in an interest-bearing demand deposit account.
2023-11-08Issued a promissory note of up to $1,500,000 to Sunorange for working capital expenses.
2023-11-30Board of Directors approved the adoption of the Executive Compensation Clawback Policy.
2023-12-27Scage Registration Statement on Form F-4 was declared effective by the SEC.
2024-01-22Received a deficiency notice from Nasdaq regarding non-compliance with the annual meeting requirement.
2024-01-26Issued a promissory note of up to $1,500,000 to Scage for working capital needs.
2024-03-07Submitted a plan to Nasdaq to regain compliance with the Annual Meeting Requirement.
2024-05-02Extraordinary General Meeting (May 2024 EGM) held, approving extension of business combination deadline to November 8, 2024.
2024-05-06Received a deficiency notice from Nasdaq regarding non-compliance with the minimum 400 total shareholders requirement.
2024-05-15Issued a promissory note of up to $225,000 to the Sponsor to support the May 2024 Extension.
2024-06-18First Amendment to Business Combination Agreement signed, reducing consideration to $800 million and extending reorganization/outside dates.
2024-07-03Received notice from Nasdaq granting continued listing subject to completing business combination by November 4, 2024.
2024-10-01Administrative Services Agreement with Sponsor terminated.
2024-10-13Amended and restated the agreement with the third-party consultant, reducing contingent fee to 0.05%.
2024-10-31Second Amendment to Business Combination Agreement signed, extending Outside Date to March 31, 2025.
2024-11-05Announced waiver of right to withdraw $50,000 of Trust Account interest for dissolution expenses.
2024-11-06Extraordinary General Meeting (November 2024 EGM) held, approving extension of business combination deadline to May 8, 2025.
2024-11-08Notified Nasdaq Panel of inability to close business combination by November 4, 2024 deadline.
2024-11-11Issued a promissory note of up to $259,588 to the Sponsor to support the November 2024 Extension.
2024-11-12Trading in company securities suspended from Nasdaq due to failure to meet listing terms; began quoting on OTC Markets.
2025-01-03Sponsor consummated a distribution of its assets, including Class A and Class B ordinary shares and private placement warrants, to its constituent members.
2025-03-24Audit Committee dismissed Marcum LLP and engaged HTL International, LLC as the new independent registered public accounting firm.
2025-03-28Extraordinary General Meeting (Scage Business Combination Meeting) held, where the business combination proposal was approved by Finnovate shareholders.
2025-04-02Third Amendment to Business Combination Agreement signed, extending Outside Date to July 31, 2025.
2025-04-21Adopted insider trading policies and procedures.
2025-04-28Nasdaq notified the company of impending delisting of its securities.
2025-05-06Extraordinary General Meeting (May 2025 EGM) held, approving extension of business combination deadline to November 8, 2025.
2025-05-21Nasdaq filed a Form 25 with the SEC to complete the delisting.
2025-06-05Date of this Annual Report on Form 10-K filing.

Recommendation

sell

Keywords

SPAC, Finnovate Acquisition Corp, Scage International Limited, Business Combination, De-SPAC, Shareholder Redemptions, Nasdaq Delisting, Trust Account, Going Concern, Financial Reporting, Promissory Notes, NEV Trucks, E-fuel Solutions, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.